MedTrace Logo

HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH Patients

NCT00199706 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-07-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether 7.2% NaCl in 6% hydroxyethyl starch will lower intracranial pressure (ICP) in SAH-patients with normal or moderately elevated ICP in a placebo controlled study, and to describe the haemodynamic effects.

Conditions

  • Subarachnoid Hemorrhage

Interventions

DRUG

7.2% NaCl in 6% hydroxyethyl starch solution

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Bentsen, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Completion
2004-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00199706 on ClinicalTrials.gov